![](/img/cover-not-exists.png)
Pazopanib-induced liver toxicity in metastatic renal cell carcinoma (mRCC) patients: Impact of UGT1A1 polymorphism on pazopanib dose reduction, safety and patient outcome
Henriksen, J.N., Bøttger, P., Hermansen, C.K., Ladefoged, S.A., Nissen, P.H., Hamilton-Dutoit, S., Fink, T.L., Donskov, F.Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2019.09.013
Date:
September, 2019
File:
PDF, 1006 KB
2019